Showing 2171-2180 of 7169 results for "".
New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/Ask Dr. Friedman
https://practicaldermatology.com/topics/psoriasis/ask-dr-friedman/23360/Answers to Your Questions About Skincare, Disease Management, and MoreContemporary African-American Hair Care Practices
https://practicaldermatology.com/topics/practice-management/contemporary-african-american-hair-care-practices/21176/As trends and sensibilities regarding hair practices shift, it is important for physicians to understand the needs of African-American patients in order to appropriately discuss healthy hair habits.Preparing for the Future of Teledermatology
https://practicaldermatology.com/issues/supplements/preparing-for-the-future-of-teledermatology/23475/Telehealth served as an important stopgap for medical providers and their patients in the context of the COVID-19 pandemic, but will it persist? And if so, how can you derive the most benefit?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20513/Pediatric Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/pediatric-hidradenitis-suppurativa/56417/A Primer for CliniciansThe State of Prevention in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/the-state-of-prevention-in-atopic-dermatitis/23183/Proton Pump Inhibitor-induced Dermal Hypersensitivity Reaction Masquerading as an Arthropod-bite Reaction
https://practicaldermatology.com/youngmd-connect/resident-resource-center/proton-pump-inhibitor-induced-dermal-hypersensitivity-reaction-masquerading-as-an-arthropod-bite-reaction/23940/Atopic Dermatitis: A Review of Common Comorbidities
https://practicaldermatology.com/topics/atopic-dermatitis/atopic-dermatitis-a-review-of-common-comorbidities/23352/It is important to acknowledge and identify comorbidities to successfully manage AD and improve patient quality of life.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.